Federica Tomao | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis	CANCERS	2024
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey	JOURNAL OF GYNECOLOGIC ONCOLOGY	2024
Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer	ARCHIVES OF GYNECOLOGY AND OBSTETRICS	2024
Advances in small molecule maintenance therapies for high-grade serous ovarian cancer	EXPERT OPINION ON PHARMACOTHERAPY	2023
Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives	HEALTHCARE	2023
Magnetic resonance imaging-radiomics in endometrial cancer: a systematic review and meta-analysis	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER	2023
Sexual dysfunctions in breast cancer patients: evidence in context	SEXUAL MEDICINE REVIEWS	2023
Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER	2023
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis	REPRODUCTIVE SCIENCES	2023
Therapeutic Approaches to Vulvar Cancer: A Review of Literature	CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY	2023
Imaging of Peritoneal Carcinomatosis in Advanced Ovarian Cancer: CT, MRI, Radiomic Features and Resectability Criteria	CANCERS	2023
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study	FRONTIERS IN ONCOLOGY	2023
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients: a prospective cohort study	VACCINES	2022
CT-based radiomics and deep learning for BRCA mutation and progression-free survival prediction in ovarian cancer using a multicentric dataset	CANCERS	2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer	GYNECOLOGIC ONCOLOGY	2022
Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients	GYNECOLOGIC AND OBSTETRIC INVESTIGATION	2022
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis	JOURNAL OF GYNECOLOGIC ONCOLOGY	2022
An update on current pharmacotherapy for vulvar cancer	EXPERT OPINION ON PHARMACOTHERAPY	2022
MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer	CANCERS	2022
Role of circulating biomarkers in platinum-resistant ovarian cancer	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021